Christian Capitini, MD, along with Co-Investigators Paul Sondel, MD, PhD, and Sean Fain, PhD (Medical Physics), were recently awarded a four-year, Research Scholar Grant from the American Cancer Society (ACS), for the project entitled, “Ex vivo activated NK cells and immunocytokine for pediatric cancers.” This grant, for $792,000 (total costs), will provide preclinical evidence for a potential platform for incorporating recently developed immunotherapies, namely immunocytokine and natural killer (NK) cells, for treatment of neuroblastoma and osteosarcoma.